Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Neurological diseases as primary gliopathies: a reassessment of neurocentrism.

Verkhratsky A, Sofroniew MV, Messing A, deLanerolle NC, Rempe D, Rodríguez JJ, Nedergaard M.

ASN Neuro. 2012 Apr 5;4(3). pii: e00082. doi: 10.1042/AN20120010. Review.

2.

The dual role of astrocyte activation and reactive gliosis.

Pekny M, Wilhelmsson U, Pekna M.

Neurosci Lett. 2014 Apr 17;565:30-8. doi: 10.1016/j.neulet.2013.12.071. Epub 2014 Jan 7. Review.

PMID:
24406153
3.

The dual face of connexin-based astroglial Ca(2+) communication: a key player in brain physiology and a prime target in pathology.

De Bock M, Decrock E, Wang N, Bol M, Vinken M, Bultynck G, Leybaert L.

Biochim Biophys Acta. 2014 Oct;1843(10):2211-32. doi: 10.1016/j.bbamcr.2014.04.016. Epub 2014 Apr 21. Review.

4.

Topiramate attenuates cerebral ischemia/reperfusion injury in gerbils via activating GABAergic signaling and inhibiting astrogliosis.

Mao X, Ji C, Sun C, Cao D, Ma P, Ji Z, Cao F, Min D, Li S, Cai J, Cao Y.

Neurochem Int. 2012 Jan;60(1):39-46. doi: 10.1016/j.neuint.2011.10.015. Epub 2011 Nov 7.

PMID:
22085431
5.

Nucleotide signaling in astrogliosis.

Franke H, Illes P.

Neurosci Lett. 2014 Apr 17;565:14-22. doi: 10.1016/j.neulet.2013.09.056. Epub 2013 Oct 5. Review.

PMID:
24103370
6.

Protective role of melatonin in domoic acid-induced neuronal damage in the hippocampus of adult rats.

Ananth C, Gopalakrishnakone P, Kaur C.

Hippocampus. 2003;13(3):375-87.

PMID:
12722978
7.

Neuronal damage using fluoro-Jade B histofluorescence and gliosis in the gerbil septum submitted to various durations of cerebral ischemia.

Park CW, Lee JC, Ahn JH, Lee DH, Cho GS, Yan BC, Park JH, Kim IH, Lee HY, Won MH, Cho JH.

Cell Mol Neurobiol. 2013 Oct;33(7):991-1001. doi: 10.1007/s10571-013-9967-y. Epub 2013 Jul 28.

PMID:
23893372
8.

[Role of calcium in physiology and pathology of neurons].

Salińska E, Łazarewicz JW.

Postepy Biochem. 2012;58(4):403-17. Review. Polish.

PMID:
23662434
9.

Astrocytic dysfunction: insights on the role in neurodegeneration.

Rossi D, Volterra A.

Brain Res Bull. 2009 Oct 28;80(4-5):224-32. doi: 10.1016/j.brainresbull.2009.07.012. Epub 2009 Jul 22. Review.

PMID:
19631259
10.

Galectin-1 attenuates astrogliosis-associated injuries and improves recovery of rats following focal cerebral ischemia.

Qu WS, Wang YH, Ma JF, Tian DS, Zhang Q, Pan DJ, Yu ZY, Xie MJ, Wang JP, Wang W.

J Neurochem. 2011 Jan;116(2):217-26. doi: 10.1111/j.1471-4159.2010.07095.x. Epub 2010 Dec 2.

11.

Ionic transporter activity in astrocytes, microglia, and oligodendrocytes during brain ischemia.

Annunziato L, Boscia F, Pignataro G.

J Cereb Blood Flow Metab. 2013 Jul;33(7):969-82. doi: 10.1038/jcbfm.2013.44. Epub 2013 Apr 3. Review.

12.

Astrocytes in Alzheimer's disease.

Verkhratsky A, Olabarria M, Noristani HN, Yeh CY, Rodriguez JJ.

Neurotherapeutics. 2010 Oct;7(4):399-412. doi: 10.1016/j.nurt.2010.05.017. Review.

13.
14.

The 5HT1A receptor agonist, 8-OH-DPAT, protects neurons and reduces astroglial reaction after ischemic damage caused by cortical devascularization.

Ramos AJ, Rubio MD, Defagot C, Hischberg L, Villar MJ, Brusco A.

Brain Res. 2004 Dec 31;1030(2):201-20.

PMID:
15571670
15.

Astroglia in dementia and Alzheimer's disease.

Rodríguez JJ, Olabarria M, Chvatal A, Verkhratsky A.

Cell Death Differ. 2009 Mar;16(3):378-85. doi: 10.1038/cdd.2008.172. Epub 2008 Dec 5. Review.

16.

Temporal differences in microRNA expression patterns in astrocytes and neurons after ischemic injury.

Ziu M, Fletcher L, Rana S, Jimenez DF, Digicaylioglu M.

PLoS One. 2011 Feb 23;6(2):e14724. doi: 10.1371/journal.pone.0014724.

17.

Astrogliosis as a therapeutic target for neurodegenerative diseases.

Colangelo AM, Alberghina L, Papa M.

Neurosci Lett. 2014 Apr 17;565:59-64. doi: 10.1016/j.neulet.2014.01.014. Epub 2014 Jan 20. Review.

18.

Astrocytes: New Targets for the Treatment of Neurodegenerative Diseases.

Finsterwald C, Magistretti PJ, Lengacher S.

Curr Pharm Des. 2015;21(25):3570-81. Review.

PMID:
26166612
19.

Severe neurodegeneration with impaired autophagy mechanism triggered by ostm1 deficiency.

Héraud C, Griffiths A, Pandruvada SN, Kilimann MW, Pata M, Vacher J.

J Biol Chem. 2014 May 16;289(20):13912-25. doi: 10.1074/jbc.M113.537233. Epub 2014 Apr 9.

20.

Astroglial Vesicular Trafficking in Neurodegenerative Diseases.

Zorec R, Parpura V, Verkhratsky A.

Neurochem Res. 2017 Mar;42(3):905-917. doi: 10.1007/s11064-016-2055-1. Epub 2016 Sep 14.

PMID:
27628292

Supplemental Content

Support Center